Minerva Neurosciences, Inc.
NERV- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001598646
No open-market purchases or sales by Minerva Neurosciences, Inc. insiders were filed in the last 90 days; 61 institutions reported holding it in 13F filings for Q2 2026, worth $234.8M in total; no superinvestor holds it.
Q2 2022 vs. Q1 2022
How the institutions holding Minerva Neurosciences, Inc. changed between Q1 2022 and Q2 2022.
All holders in Q2 2022All holders in Q1 2022
| Measure | Q1 2022 | Q2 2022 | Change |
|---|---|---|---|
| Holders | 33 | 23 | −10 |
| SharesConverted for a 1-for-8 split | 2.46M | 2.27M | −191.7K (−7.8%) |
| Value | $16.3M | $7.51M | −$8.83M (−54.0%) |
New holders (3)
Institutions that held Minerva Neurosciences, Inc. at the end of Q2 2022 but not at the end of Q1 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Barclays PLC | 8,430 | $28.0K | 0.00% |
| Group One Trading, L.P. | 5,869 | $19.0K | 0.00% |
| Citigroup Inc | 2,125 | $7.00K | 0.00% |
Sold out (13)
Institutions that held Minerva Neurosciences, Inc. at the end of Q1 2022 and filed for Q2 2022 without it.
| Institution | Shares, Q1 2022 | Value, Q1 2022 |
|---|---|---|
| Armistice Capital, LLC | 1,024,000 | $850.0K |
| D. E. Shaw & Co., Inc. | 91,355 | $76.0K |
| Northern Trust Corp | 65,555 | $54.0K |
| Susquehanna International Group, LLP | 56,292 | $47.0K |
| Bailard, Inc. | 24,400 | $20.0K |
| Sanders Morris Harris LLC | 24,000 | $20.0K |
| Bank of New York Mellon Corp | 19,705 | $16.0K |
| Two Sigma Securities, LLC | 17,123 | $14.0K |
| Cambridge Investment Research Advisors, Inc. | 13,900 | $12.0K |
| Citadel Advisors LLC | 14,733 | $12.0K |
| Good Life Advisors, LLC | 10,000 | $8.00K |
| BNP Paribas Arbitrage, SA | 533 | $442 |
| Bank of America Corp | 144 | $0 |